Literature DB >> 876934

Treatment of acute hepatic encephalopathy with L-dopa.

T Chajek, E M Berry, G Friedman, O Abramsky.   

Abstract

A clinical report of a 30-year-old woman who developed acute hepatic failure in the fifth month of pregnancy is presented. L-dopa administration resulted in a marked improvement in both level of consciousness and electroencephalogram. The literature dealing with L-dopa therapy in hepatic encephalopathy is reviewed.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 876934      PMCID： PMC2496557          DOI： 10.1136/pgmj.53.619.262

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  12 in total

1.  Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa.

Authors:  O Abramsky; Z Goldschmidt
Journal:  Surgery       Date:  1974-02       Impact factor: 3.982

2.  Treatment of hepatic coma and hepatorenal syndrome. Mechanism of action of L-dopa and aramine.

Authors:  J E Fischer; J H James
Journal:  Am J Surg       Date:  1972-02       Impact factor: 2.565

3.  Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

Authors:  B G Gazzard; M J Weston; I M Murray-Lyon; H Flax; C O Record; R Williams; B Portmann; P G Langley; E H Dunlop; P J Mellon; M B Ward
Journal:  Lancet       Date:  1974-06-29       Impact factor: 79.321

4.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

5.  [Levodopa treatment in hepatic coma (with special consideration of serial EEG changes (author's transl)].

Authors:  G Lanzinger; B Kommerell
Journal:  Dtsch Med Wochenschr       Date:  1974-04-05       Impact factor: 0.628

6.  Extracorporal circulation in hypothermia as used for total-body washout in stage IV hepatic coma.

Authors:  R E Cline; G Klebanoff; R G Armstrong; W Stanford
Journal:  Ann Thorac Surg       Date:  1973-07       Impact factor: 4.330

7.  Levodopa in hepatic failure.

Authors:  M Stefanini; E N Hetherington
Journal:  JAMA       Date:  1972-05-29       Impact factor: 56.272

8.  [Treatment of hepatic coma with L-dopa. Preliminary results].

Authors:  A Sarrazin; J Emerit; L Olivier; F Rebelo; O Bousquet
Journal:  Presse Med       Date:  1971-11-20       Impact factor: 1.228

9.  Levodopa in hepatic coma.

Authors:  J D Parkes; P Sharpstone; R Williams
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

10.  Treatment of chronic hepatic encephalopathy with levodopa.

Authors:  M Lunzer; I M James; J Weinman; S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059
View more
  2 in total

1.  Pathophysiological changes associated with increasing grade of hepatic encephalopathy.

Authors:  R Eliakim; D Shouval; M Eliakim
Journal:  J Natl Med Assoc       Date:  1988-09       Impact factor: 1.798

2.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.